Mode-of-action of T-cell immunotherapies in focus (VIDEO)
Caption
A new 3D imaging technique brings the working mode of T-cell immunotherapies into live view. Dr. @florijn Dekkers and dr. @maria Alieva, both working in the Rios group, developed imaging and analysis technology BEHAV3D. Researchers plan to use this platform to improve T-cell therapies for solid tumors by analyzing the interaction between T-cell therapies and solid tumor organoids.
Credit
Research group dr. Anne Rios - Princess Máxima Center for Pedriatic Oncology, Utrecht, the Netherlands.
Usage Restrictions
Mentioning of credits is mandatory
License
Original content